Overview

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Status:
Completed

Trial end date:
2005-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Ciclesonide